Gilead's lenacapavir reduced HIV infections by 96% in trial

A pharmacist holds a bottle of lenacapavir, the new injectable drug for HIV prevention. Nardus Engelbrecht | AP GileadPfizer's twice-yearly…

Eli Lilly and drug makers show data on weight loss drugs

An injectable pen of Zepbound, Eli Lilly's weight loss drug, is on display in New York City on December 11,…